Table 2

Renal characteristics, resource utilisation and hospital outcomes during entire hospitalisation by trajectories of AKI in all cohort

VariablesAll subjects
(N=355 678)
AKI
(N=54 212, 15%)
Persistent AKI without renal recovery (N=14 122, 4%)Persistent AKI with renal recovery (N=8590, 2%)Rapidly reversed AKI (N=31 500, 9%)No AKI
(N=301 466, 85%)
Renal characteristics during entire hospitalisation
Worst AKI staging, n (%)
 Stage 136 258 (10)36 258 (67)*5210 (37)*†‡4176 (49)*†26 872 (85)*0 (0)
 Stage 29551 (3)9551 (18)*3762 (27)*†‡2492 (29)*†3297 (10)*0 (0)
 Stage 38403 (2)8403 (16)*5150 (36)*†‡1922 (22)*†1331 (4)*0 (0)
  Stage three without RRT6351 (2)6351 (12)*3384 (24)*†‡1646 (19)*†1321 (4)*0 (0)
  Stage three with RRT2052 (1)2052 (4)*1766 (13)*†‡276 (3)†10 (0)*0 (0)
 AKI duration, days, median (IQR)2 (1–4)2 (1–4)5 (3–9) b‡4 (3–7)1 (1–2)NA
 Recurrent AKI, n (%)6466 (2)6466 (12)*2173 (15)*†‡1957 (23)*†2336 (7)*0 (0)
 No renal recovery at discharge/death, n (%)22 240 (6)22 240 (41)*14 122 (100)*†‡0 (0)†8118 (26)*0 (0)
Resource utilisation during entire hospitalisation
 Hospital days, median (IQR)3 (1–6)7 (4–14)*8 (4–15)*†‡14 (8–24)*†6 (3–10)*2 (1–5)
 Admission to ICU, n (%)78 769 (22)27 711 (51)*8573 (61)*†‡5860 (68)*†13 278 (42)*51 058 (17)
  Days in ICU, median (IQR)4 (2–7)6 (3–12)*6 (3–13)*†‡9 (5–18)*†5 (3–9)*3 (–5)
 Mechanical ventilation, n (%)23 286 (7)11 876 (22)*4779 (34)*†2876 (33)*†4221 (13)*11 410 (4)
  Mechanical ventilation calendar days, median (IQR)3 (2–6)4 (2–9)*4 (2–9)*†‡5 (2–12)*†3 (2–7)*2 (1–4)
 Vasopressor or inotropes used, n (%)55 415 (16)17 261 (32)*6016 (43)*†3781 (44)*†7464 (24)*38 154 (13)
Hospital disposition, n (%)
 Hospital mortality7799 (2)4974 (9)*3918 (28)*†‡376 (4)*†680 (2)*2825 (1)
 Another hospital, LTAC, SNF, Hospice34 092 (10)10 028 (18)*3011 (21)*†‡2494 (29)*†4523 (14)*24 064 (8)
 Home/rehab313 787 (88)39 210 (72)*7193 (51)*†‡5720 (67)*†26 297 (83)*274 577 (91)
 30-day outcomes (among survivors), n (%)347 87949 238 (14)10 204 (3)8214 (2)30 820 (9)298 641 (86)
 Death in 30 days of discharge4934 (1)1776 (4)*570 (6)*†418 (5)*†788 (3)*3158 (1)
 Trajectory group for encounter with readmission within 30 days of discharge83 592 (24)12 748 (26)*2528 (25)‡2381 (29)*†7839 (25)*70 844 (24)
  Persistent AKI with no renal recovery2764 (3)1297 (10)*536 (21)*†‡223 (9)*†538 (7)*1467 (2)
  Persistent AKI with renal recovery2118 (3)933 (7)*231 (9)*†239 (10)*†463 (6)*1185 (2)
  Rapidly reversed AKI7505 (9)2504 (20)*502 (20)*448 (19)*1554 (20)*5001 (7)
  No AKI59 164 (71)7096 (56)*1100 (44)*†‡1337 (56)*†4659 (59)*52 068 (73)
  Unknown12 041 (14)918 (7)159 (6)*†134 (6)*†625 (8)*11 123 (16)
Other complications during entire hospitalisation
 Venous thromboembolism, n (%)15 755 (4)5180 (10)*1589 (11)*†‡1290 (15)*†2301 (7)*10 575 (4)
 Sepsis, n (%)29 836 (8)13 995 (26)*5102 (36)*†‡3275 (38)*†5618 (18)*15 841 (5)
 Cardiovascular complication, n (%)31 780 (9)15 229 (28)*5553 (39)*†3469 (40)*†6207 (20)*16 551 (5)
 Thirty-day mortality, n (%)11 082 (3)5655 (10)*3962 (28)*†‡506 (6)*†1187 (4)*5427 (2)
 One-year mortality, n (%)34 687 (10)12 570 (23)*5802 (41)*†‡2054 (24)*†4714 (15)*22 117 (7)
 Three-year mortality, n (%)49 144 (14)15 703 (29)*6414 (45)*†‡2669 (31)*†6620 (21)*33 441 (11)
  • *P<0.05 compared with rapidly no AKI.

  • †P<0.05 compared with rapidly reversed AKI.

  • ‡P<0.05 compared with persistent AKI with renal recovery.

  • AKI, acute kidney injury; ICU, intensive care unit; LTAC, long-term acute care hospital; NA, not applicable; RRT, renal replacement therapy; SNF, skilled nursing facility.